Vera Therapeutics Inc.

NASDAQ: VERA · Real-Time Price · USD
22.02
-3.51 (-13.75%)
At close: May 06, 2025, 3:59 PM
22.59
2.59%
Pre-market: May 07, 2025, 04:43 AM EDT

Vera Therapeutics Statistics

Share Statistics

Vera Therapeutics has 63.77M shares outstanding. The number of shares has increased by 16.54% in one year.

Shares Outstanding 63.77M
Shares Change (YoY) 16.54%
Shares Change (QoQ) 0.67%
Owned by Institutions (%) 99.99%
Shares Floating n/a
Failed to Deliver (FTD) Shares 20,819
FTD / Avg. Volume 2.04%

Short Selling Information

The latest short interest is 6.08M, so 9.6% of the outstanding shares have been sold short.

Short Interest 6.08M
Short % of Shares Out 9.6%
Short % of Float 12.81%
Short Ratio (days to cover) 5.33

Valuation Ratios

The PE ratio is -15.38 and the forward PE ratio is -8.06. Vera Therapeutics's PEG ratio is -0.69.

PE Ratio -15.38
Forward PE -8.06
PS Ratio 0
Forward PS 1.8
PB Ratio 4.05
P/FCF Ratio -17.25
PEG Ratio -0.69
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Vera Therapeutics.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 25.67, with a Debt / Equity ratio of 0.09.

Current Ratio 25.67
Quick Ratio 25.67
Debt / Equity 0.09
Debt / EBITDA -0.33
Debt / FCF -0.4
Interest Coverage 21.92

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee n/a
Profits Per Employee $-1,358,464.29
Employee Count 112
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax 1K
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by -51.07% in the last 52 weeks. The beta is 1.28, so Vera Therapeutics's price volatility has been higher than the market average.

Beta 1.28
52-Week Price Change -51.07%
50-Day Moving Average 25.07
200-Day Moving Average 36.41
Relative Strength Index (RSI) 42.8
Average Volume (20 Days) 1,020,478

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -167.17M
Net Income -152.15M
EBITDA -167.17M
EBIT -159.77M
Earnings Per Share (EPS) -2.75
Full Income Statement

Balance Sheet

The company has 92.65M in cash and 54.64M in debt, giving a net cash position of 38.01M.

Cash & Cash Equivalents 92.65M
Total Debt 54.64M
Net Cash 38.01M
Retained Earnings -461.25M
Total Assets 655.68M
Working Capital 625.85M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -134.68M and capital expenditures -972K, giving a free cash flow of -135.65M.

Operating Cash Flow -134.68M
Capital Expenditures -972K
Free Cash Flow -135.65M
FCF Per Share -2.45
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

VERA does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for VERA is $68, which is 208.8% higher than the current price. The consensus rating is "Buy".

Price Target $68
Price Target Difference 208.8%
Analyst Consensus Buy
Analyst Count 9
Stock Forecasts

Scores

Altman Z-Score 11.76
Piotroski F-Score 2